Fusion gene-associated TL was first described in chronic myeloid leukemia (CML)2,3, in which a specific TL, i.e. t(9;22), is frequently observed, and BCR-ABL fusion gene transcripts are expressed in leukemia cells. This evidence concerns the gene BCR and leukemia.